Latest Ipsen News & Updates
See the latest news and media coverage for Ipsen. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global specialty biopharmaceutical company
ipsen.com- Headquarters
- Paris, France
- Company type
- Public company
- Number of employees
- 6,500–10,000
Latest news about Ipsen
Company announcements
-
Ipsen delivers strong Q1 2026 sales
Total sales grow 22.6% at CER. Confirms full-year guidance. Expects three Phase III readouts in H2.
-
Ipsen announces EU approval of Ojemda
The EC granted conditional marketing authorization for tovorafenib for children six months and older with relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration.
-
Ipsen announces Beech Tree exemption from tender offer
Beech Tree, holding 26.03% of Ipsen shares, received exemption from French AMF due to stake transfer to Alasol Foundation, with governance agreement.
-
Ipsen provides clarifications on Henri Beaufour succession
Beech Tree, Altawin, and Fondation Alasol enter governance agreement ensuring share retention and non-interference in management. Awaits AMF waiver.
Media coverage
-
Ipsen outperforms expectations in the first quarter, the rest of the year will be rich in key clinical announcements
The pharmaceutical laboratory starts the year with a bang with very strong growth in its activity. The upcoming announcement of targeted acquisitions but also of important clinical results...
-
Ipsen obtains European Union approval for Ojemda, targeted therapy against relapsed or refractory pediatric low-grade glioma
Ipsen announced that the European Commission has granted conditional marketing authorization for Ojemda as monotherapy for the treatment of...
-
Ipsen-CA +22.6% in Q1 to €1.07 bn, targets confirmed
April 23 (Reuters) - Ipsen announced on Thursday a 22.6% growth at constant exchange rates in its sales for the first quarter, which...
-
Ipsen S.A. - Information relating to the holding of the Combined Shareholders' Meeting of 13 May 2026
PARIS, FRANCE, 22 APRIL 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Shareholders of the Company are invited to participate in the...
Track Ipsen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Ipsen competitors & trending companies
Browse news for competitors to Ipsen and other trending companies.
Biogen
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group